Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04152486
Recruitment Status : Active, not recruiting
First Posted : November 5, 2019
Last Update Posted : August 18, 2020
Sponsor:
Collaborators:
Epicentre
Ministère de la Santé de la RDC
Médecins Sans Frontières, France
Coalition for Epidemic Preparedness Innovations
Janssen Vaccines & Prevention B.V.
Public Health England
Information provided by (Responsible Party):
London School of Hygiene and Tropical Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2021